Key Takeaways Global healthcare rebounded late in 2025 as U.S. drug pricing uncertainty eased, driving strong ETF inflows.Policy clarity, aging populations, and AI innovation are key drivers for healthcare growth in 2026.VHT, XLV and IXJ offer diversified exposure to healthcare's recovery while reducing single-stock risk.2025 was a tumultuous year for the global healthcare sector. For much of the year, policy uncertainty, particularly around U.S. drug pricing and trade barriers, weighed heavily on valuation ...